BALTIMORE--(BUSINESS WIRE)--April 7, 2005--Univec, Inc. (OTCBB: UNVC) a pharmaceutical, pre-filled and safety syringe healthcare organization announces joint venture completed with Vista-Pharm.
David L. Dalton, President and CEO of Univec stated, "Completion of this joint venture with Vista-Pharm adds to Univec's portfolio of products and services that fits our business model. We anticipate continuing to expand production and diversity of product to sure up profitability. Vista-Pharm's Methadone line of products as well as other difficult and highly regulated pharmaceuticals adds to the value of the Univec brand."
